Filter
1125
Filtered Results: 1125
Text search:
The
Center
for
Health
Market
Innovations.
Featured
Recommendations
87
New Publications
296
Language
Document type
No document type
553
Studies & Reports
293
Guidelines
109
Strategic & Response Plan
97
Manuals
49
Training Material
9
Fact sheets
8
Situation Updates
5
Resource Platforms
2
Countries / Regions
Global
66
India
45
Kenya
38
Sierra Leone
27
Uganda
25
Ethiopia
24
Liberia
23
Nepal
23
South Africa
20
Western and Central Europe
20
Ghana
19
Zambia
19
Africa
19
Nigeria
17
Bangladesh
16
Congo, Democratic Republic of
15
Syria
15
Rwanda
15
Malawi
15
Senegal
13
Latin America and the Carribbean
13
Guinea
12
Myanmar / Burma
12
South–East Asia Region
11
Philippines
10
Tanzania
10
Thailand
10
Asia
10
Ukraine
9
West and Central Africa
9
South Sudan
8
Zimbabwe
7
Haiti
7
Cambodia
7
Indonesia
7
Eastern Europe
7
Cameroon
6
Germany
6
China
6
Mozambique
6
Colombia
6
East and Southern Africa
6
Lebanon
5
Burkina Faso
4
Jordan
4
Afghanistan
4
Namibia
4
Brazil
4
Eastern Europe and Central Asia
4
Laos
4
Mali
3
USA
3
Somalia
3
Central African Republic
3
Lesotho
3
Sri Lanka
3
Yemen
3
Middle East and North Africa
3
Russia
3
Moldova
3
Georgia
3
Iraq
2
Turkey
2
Egypt
2
Papua New Guinea
2
Sudan
2
Argentina
2
Peru
2
Botswana
2
Vietnam
2
Morocco
1
Niger
1
Pakistan
1
Chad
1
Gambia
1
Mauritania
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Bolivia
1
Angola
1
Mexico
1
Chile
1
Venezuela
1
Djibouti
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Lithuania
1
Kyrgyzstan
1
Turkmenistan
1
Jamaica
1
Japan
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
392
Public Health
74
Key Resources
72
Clinical Guidelines
53
Women & Child Health
28
Pharmacy & Technologies
12
Capacity Building
7
Toolboxes
COVID-19
95
Planetary Health
88
HIV
73
Mental Health
66
AMR
60
TB
50
Global Health Education
44
Disability
41
Health Financing Toolbox
35
NTDs
31
Ebola
28
Conflict
28
Refugee
21
Caregiver
21
Pharmacy
17
Natural Hazards
15
Rapid Response
15
NCDs
14
Polio
4
Social Ethics
3
Cholera
2
Typhoon
1
Health Financing
1
Despite recent global declines, under-five mortality remains high in many of the poorest countries. Barriers to timely
quality care, including user fees, distance to facilities and the availabilit...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of ... deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisive role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
The objective of this study is to analyze the strengths, weaknesses, sustainability, and impact of the tsunami response in Sri Lanka and Indonesia ...
While many of the countries hit by the COVID-19 in the first few months of the year are now begi...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified...
The Camp Managment Toolkit
recommended
Applicable to both IDP and refugee scenarios, the Toolkit incorporates a wide range of relevant information on managing displaced populations living in communal settings (collective centres, spontaneous sites, established camps, etc.). Large scale d...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards ...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detec...
This document provides a systematic approach in developing a coordinated, standardized, reliable, efficient, cost-effective, and sustainable specimen transport and referral system to support IVHD and VL testing networks. This document provides technical and programmatic recommendations on ... appropriate specimen storage and transportation of specimens for HIV VL and IVHD testing. Along with the national guidelines for specimen storage and transport, these standards should provide guidance on the creation or improvement of specimen referral networks and specimen transport systems. In addition, standard operating procedures (SOPs) targeting drivers and persons responsible for packing of specimens and results return are included in this document.
No publication year indicated in the document.
No publication year indicated in the document.
Rabies is a devastating and societally important zoonotic disease, which is transmitted principally to humans through the bite of infected dogs. This acute, progressive viral encephalitis has the hi...
OECD Development Policy Tools
Recognising that donor policies and responses constantly evolve, this guidance recommends that donors operating in situations of forced displacement prioritise three broad areas of work, where they can best contribute to existing capacities at ... national, regional and global levels.
Recognising that donor policies and responses constantly evolve, this guidance recommends that donors operating in situations of forced displacement prioritise three broad areas of work, where they can best contribute to existing capacities at ... national, regional and global levels.
In response to a call by the United Nations Secretary-General and the Governments of Guinea, Liberia and Sierra Leone, an international team conducted an Ebola Recovery Assessment.... aim was to contribute towards laying the foundation for short-, medium- and long-term recovery while the medical emergency response continues to tackle the epidemic.
This summary report is based on a full report as well as three detailed reports submitted to each of the three governments as contributions to their national recovery planning processes.
Conflicts and disasters, including pandemics, affect women and men in all their diversity differently, and women and girls often suffer the most. Crisis-related hardships combine and compound pre-existing disadvantages, ... example, they often cause women’s working conditions to worsen while increasing their overall workload and care responsibilities. At the same time, crises can give rise to changes that enable women to take up roles that were previously available only to men, and crises can open opportunities to address existing gender-based discrimination and violations of rights.
Full Report.
In response to a call by the United Nations Secretary-General and the Governments of Guinea, Liberia and Sierra Leone, an international team conducted an Ebola Recovery Assessment. ... aim was to contribute towards laying the foundation for short-, medium- and long-term recovery while the medical emergency response continues to tackle the epidemic. This report is a contribution to ongoing efforts by the Governments of Guinea, Liberia and Sierra Leone to design their national Ebola virus disease recovery strategies
Democratic dispensation in 1994 created a political and social platform that reshaped life in South Africa. There was a surge in common belief that the inequity and wrong of Apartheid should and could be rectified. Equity of access to water and sani...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which ... pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
With eleven years left to achieve the ambitious goals of the 2030 Agenda, how close are OECD countries to reaching the SDGs? And how is our underst...
This study has been produced jointly by Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, a federally owned enterprise, implementing development programmes on behalf of the German Government, and CBM, a non-governmental organisation. Accor...
Introduction to Low Cost Sanitation
recommended
Planning, Promotion, Contruction & Design. Manual
